Home > Insider Trading > Filing (0001209191-12-019337)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138400	Biomimetic Therapeutics Inc.	BMTI	Surgical & Medical Instruments & Apparatus (3841)	621786244

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1375095	E Gary Friedlaender	Biomimetic Therapeutics, Inc. 389 Nichol Mill Lane Franklin TN 37067		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-19	5,000	$2.20	33,995	No	4	P	Direct
Common Stock	Acquisiton	2012-03-19	5,000	$2.18	14,894	No	4	P	Indirect	In Trust for Son
Common Stock	Acquisiton	2012-03-19	5,000	$2.19	11,762	No	4	P	Indirect	In Trust for Daughter

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	In Trust for Son
No	4	P	Indirect	In Trust for Daughter

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,258	Indirect	As Custodian for Grandson
Common Stock	3,377	Indirect	As Custodian for Granddaughter
Common Stock	4,258	Indirect	As Custodian for Granddaughter

Footnotes

This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $2.18 and $2.20. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $2.17 and $2.19. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
Dr. Friedlaender disclaims beneficial ownership of these shares.
This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $2.1882 and $2.19. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.